Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine authorized for use in Europe

Highlights from Chemistry Europe, ACES, and GDCh journals

Real-time monitoring of nicotine exposure, e.g., from vaping

Wastewater samples from ten countries analyzed to shed light on the drug market

Overview of the latest issue of Angewandte Chemie

A look behind the scenes at two cases that illustrate the different approaches used in forensic toxicology

Polymersome particles could provide new antimicrobial strategies against melioidosis

Data from phase 3 trial of the Moderna vaccine could help to develop measurements for immunity

Novo Nordisk to acquire Dicerna Pharmaceuticals

Protecting-group-free kilogram-scale synthesis and efficient crystallization